Results 161 to 170 of about 2,616 (196)

Predicting a therapeutic cut‐off serum level of itraconazole in recalcitrant tinea corporis and cruris—A prospective trial

Mycoses, 2021
Ananta Khurana, Ashutosh Singh, Kabir sardana   +2 more
exaly  

Tinea Versicolor

Archives of Dermatology, 1977
openaire   +2 more sources

Tinea Versicolor

2011
Nooshin K. Brinster, Vincent Liu, A. Hafeez Diwan, Phillip H. McKee   +3 more
  +4 more sources

Pityriasis Versicolor/Tinea Versicolor

2022
openaire   +1 more source

Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation

Antimicrobial Agents and Chemotherapy, 2021
Kabir sardana, Aastha Gupta, Ananta Khurana   +2 more
exaly  

Tinea Versicolor

International Journal of Dermatology, 1980
openaire   +2 more sources

Risk factors for scabies, tungiasis, and tinea infections among schoolchildren in southern Ethiopia: A cross-sectional Bayesian multilevel model

PLoS Neglected Tropical Diseases, 2021
Hiwot Hailu Amare
exaly  

Tinea versicolor (pityriasis versicolor)

2018
Aditya K. Gupta, Elizabeth A. Cooper, Kelly A. Foley   +2 more
openaire   +1 more source

Indian association of dermatologists, venereologists and leprologists (IADVL) task force against recalcitrant tinea (ITART) consensus on the management of glabrous tinea (INTACT)

Indian Dermatology Online Journal, 2020
Sunil Dogra, Ananta Khurana, Kabir sardana   +2 more
exaly  

Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review

Indian Dermatology Online Journal, 2016
Rahul Mahajan, Alok Kumar Sahoo
exaly